Skip to content
Gene-edited food is coming, but will shoppers buy?Adam Davies2020-08-14T16:18:18-05:00
Medical Alley Q3 Breakdown: All Major Sectors in Medical Alley Break $100 Million Raised for First TimeAdam Davies2020-08-14T16:18:43-05:00
Recombinetics to channel more funding into animal gene editing businessAdam Davies2020-08-14T16:18:57-05:00
NIH Awards $86 Million ($4M for 5 years to Recombinetics) to Improve Genome Editing TechniquesAdam Davies2020-08-14T16:19:20-05:00
Developing Genome Editing Solutions for BTBAdam Davies2020-08-14T16:19:43-05:00
This Week in Dairy featuring Tad Sonstegard on gene editingAdam Davies2020-08-14T16:20:03-05:00
St. Paul gene editing firm, Mayo partner to grow human heart cells in pigsAdam Davies2020-08-14T16:20:23-05:00
TARGET-TB with researchers to develop genome editing solutions for bovine tuberculosisAdam Davies2020-08-14T16:20:38-05:00
Scientists Team Up to Tackle Cattle TuberculosisAdam Davies2020-08-14T16:21:05-05:00
Recombinetics Launches TARGET-TB with Researchers in the Republic of Ireland and Northern Ireland to Develop Genome Editing Solutions for Bovine TuberculosisAdam Davies2020-08-14T16:21:23-05:00
Page load link